Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-26

Clinical Trial Update: OPTI-FREE® PureMoist® for Presbyopic Contact Lens Wearers [NA]

View source ↗

Summary

Clinical trial update for OPTI-FREE PureMoist contact lens solution in presbyopic wearers. The study is completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OPTI-FREE PureMoist

Snippet

Sponsor: Alcon, a Novartis Company | Conditions: Presbyopia | NA | Status: COMPLETED | Results posted: 2018-04-26